Long-term survival on LVAD support: Device complications and end-organ dysfunction limit long-term success
The Journal of Heart and Lung Transplantation(2022)
摘要
Success with LVAD therapy hinges on achieving long term survival in more recipients. After 1 year, extended survival is heavily constrained by the occurrence of adverse events and postoperative end-organ dysfunction. The growth of destination therapy intent mandates that future LVAD studies be designed with follow up sufficient for capturing outcomes beyond 24 months.
更多查看译文
关键词
LVAD,survival,risk factors,complications
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要